from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2378c/mbtG

LFCtreatmentdescriptionclass of inhibitor

-0.022

Amikacinug/mL Amikacintranslation

0.311

Cap5-10ug/mL Capreomycintranslation

-0.035

Rox10-50 ug/mL Roxithromycintranslation

0.703

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.158

Rif0.2-5ug/mL Rifampicintranscription

-0.087

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.830

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.238

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.572

CPZ10-50 ug/mL Chlorpromazinerespiration

3.458

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.366

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.600

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.567

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.369

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.596

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.096

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.267

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.311

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.205

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.424

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.470

Nigericin50 uM Nigericinrespiration

-0.305

TRC10-150 ug/mL Triclosanrespiration

-0.782

TRZ10-25 ug/mL Thioridazinerespiration

-0.193

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.365

menadione6-10 ug/mL Menadionerespiration

1.661

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.864

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.220

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.918

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.021

NRP_1Non-replicating persistence stage 1dosRassociated

0.145

Amp0.2mg/mL AmpicillincellWall

-0.442

Cephalexin20-100 ug/mL CephalexincellWall

0.121

Cerulenin0.32-5 ug/mL CerulenincellWall

0.816

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.418

EMB10-20 ug/mL EthambutolcellWall

0.053

Eta12-40 ug/mL EthionamidecellWall

-0.335

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.363

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.636

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.484

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.404

BZA0.12 mg/mL BenzamidearomaticAmides

0.232

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.008

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.300

H2O24 mM hydrogen peroxideDNAdamaging

-0.342

Levo10 ug/mL LevofloxacinDNAdamaging

-0.160

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.024

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.082

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.125

UVUV-irradiationDNAdamaging

-0.013

ARP41-4 ug/mL Antitubercular compound ARP4?

0.306

Antimycin12.5-50 ug/mL Antimycin A?

-0.793

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.653

PA_110-50 ug/mL Antitubercular compound PA-1?

0.452

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.245

PA8240.2-2 ug/mL PA-824?

-0.143

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.213

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.627

Verapamil50 uM Verapamil?

-0.811

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.147

methoxatin10-20 ug/mL Methoxatin?